Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Madrigal Pharmaceuticals- Inc. (MDGL)

237.82 -0.43 (-0.18%)

08-17 16:00

Open:

238.25

Pre. Close:

238.25

High:

239.99

Low:

232

Volume:

91,503

Market Cap:

3654M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

240.549 - 241.734

241.734 - 242.695

Low:

228.752 - 230.35

230.35 - 231.645

Close:

235.554 - 238.004

238.004 - 239.991

Technical analysis  (as of: 2018-08-17 4:27:59 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 313.52     One year: 346.79

Support:

Support1: 222.35    Support2: 185.00

Resistance:

Resistance1: 268.43    Resistance2: 296.91

Pivot:

243.41

Moving Averages:

MA(5): 234.63     MA(20): 252.08

MA(100): 206.03     MA(250): 128.54

MACD:

MACD(12,26): -10.60     Signal(12,26,9): -9.12

%K %D:

%K(14,3): 25.57     %D(3): 21.65

RSI:

RSI(14): 37.00

52-Week:

High: 325.98  Low: 15.53  Change(%): 1379.9

Average Vol(K):

3-Month: 39646  10-Days 22372

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MDGL has closed above bottom band by 35.2%. Bollinger Bands are 43.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDGL's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-08-06T07:57:30-04:00
Premarket analyst action - healthcare

2018-08-06T06:21:25-04:00
Viking Therapeutics: A Strong Grower To Service The Lucrative NASH Market

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

15.37

Shares Float (M)

6.69

% Held by Insiders

61.00

% Held by Institutions

42.30

Shares Short (K)

1029

Shares Short Prior Month (K)

Stock Financials

EPS

-2.250

EPS Est. Current Year

-2.670

EPS Est. Next Year

-3.560

EPS Est. Next Quarter

-0.750

Forward EPS

-5.819

Book Value (p.s.)

7.350

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-10.6

Return on Equity (ttm)

-10.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.544

Qtrly Earnings Growth

Operating Cash Flow (M)

-24.90

Levered Free Cash Flow (M)

-15.98

Valuation

P/E

-105.70

P/E Growth Ratio

P/BV

32.36

P/S

P/CF

-146.77

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-07-25

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.